Filters
Sort results
Reset
Apply
Cat No. | Products Name | Name | Previous Name | Target | Format | Options | Order | quote |
|---|---|---|---|---|---|---|---|---|
Pre-Made Afutuzumab biosimilar, Whole mAb, Anti-MS4A1/CD20 Antibody: Anti-B1/Bp35/CVID5/FMC7/LEU-16/S7 therapeutic antibody |
Afutuzumab |
Obinutuzumab |
MS4A1/CD20 |
Whole mAb |
||||
Pre-Made Blontuvetmab biosimilar, Canine Whole mAb, Anti-MS4A1/CD20 Antibody: Anti-B1/Bp35/CVID5/FMC7/LEU-16/S7 therapeutic antibody |
Blontuvetmab |
NA |
MS4A1/CD20 |
Canine Whole mAb |
||||
Pre-Made Divozilimab biosimilar, Whole mAb, Anti-MS4A1/CD20 Antibody: Anti-B1/Bp35/CVID5/FMC7/LEU-16/S7 therapeutic antibody |
Divozilimab |
NA |
MS4A1 |
Whole mAb |
||||
Pre-Made Envafolimab biosimilar, Single Domain Variable Fragment;H, Anti-CD274/PD-L1 Antibody: Anti-B7-H, B7H1, PD-L1, PDCD1L1, PDCD1LG1, PDL1, hPD-L1 therapeutic antibody |
Epcoritamab |
NA |
CD3E,MS4A1 |
Bispecific mAb |
||||
Pre-Made Glofitamab biosimilar, Bispecific mAb with Domain Crossover, Anti-CD3E;MS4A1/CD20 antibody: Anti-T3E/TCRE/IMD18/CD3epsilon;B1/Bp35/CVID5/FMC7/LEU-16/S7therapeutic antibody |
Glofitamab |
NA |
CD3E,MS4A1 |
Bispecific mAb with Domain Crossover |
||||
Pre-Made Mosunetuzumab biosimilar, Bispecific mAb, Anti-CD3E;MS4A1/CD20 Antibody: Anti-T3E/TCRE/IMD18/CD3epsilon;B1/Bp35/CVID5/FMC7/LEU-16/S7 therapeutic antibody |
Mosunetuzumab |
NA |
CD3E,MS4A1 |
Bispecific mAb |
||||
Pre-Made Obinutuzumab biosimilar, Whole mAb, Anti-MS4A1/CD20 Antibody: Anti-B1/Bp35/CVID5/FMC7/LEU-16/S7 therapeutic antibody |
Obinutuzumab |
Afutuzumab |
MS4A1 |
Whole mAb |
||||
Pre-Made Ocaratuzumab biosimilar, Whole mAb, Anti-MS4A1/CD20 Antibody: Anti-B1/Bp35/CVID5/FMC7/LEU-16/S7 therapeutic antibody |
Ocaratuzumab |
NA |
MS4A1 |
Whole mAb |
||||
Pre-Made Ocrelizumab biosimilar, Whole mAb, Anti-MS4A1/CD20 Antibody: Anti-B1/Bp35/CVID5/FMC7/LEU-16/S7 therapeutic antibody |
Ocrelizumab |
NA |
MS4A1 |
Whole mAb |
||||
Pre-Made Odronextamab biosimilar, Bispecific mAb, Anti-MS4A1/CD20;CD3E Antibody: Anti-B1/Bp35/CVID5/FMC7/LEU-16/S7;T3E/TCRE/IMD18 therapeutic antibody |
Odronextamab |
NA |
MS4A1,CD3E |
Bispecific mAb |
||||
Pre-Made Ofatumumab biosimilar, Whole mAb, Anti-MS4A1/CD20 Antibody: Anti-B1/Bp35/CVID5/FMC7/LEU-16/S7 therapeutic antibody |
Ofatumumab |
NA |
MS4A1 |
Whole mAb |
||||
Pre-Made Plamotamab biosimilar, Bispecific Mixed mAb and scFv, Anti-MS4A1/CD20;CD3E Antibody: Anti-B1/Bp35/CVID5/FMC7/LEU-16/S7;T3E/TCRE/IMD18 therapeutic antibody |
Plamotamab |
NA |
MS4A1,CD3E |
Bispecific Mixed mAb and scFv |
||||
Pre-Made Ripertamab biosimilar, Whole mAb, Anti-MS4A1/CD20 Antibody: Anti-B1/Bp35/CVID5/FMC7/LEU-16/S7 therapeutic antibody |
Ripertamab |
NA |
MS4A1 |
Whole mAb |
||||
Pre-Made Rituximab biosimilar, Whole mAb, Anti-MS4A1/CD20 Antibody: Anti-B1/Bp35/CVID5/FMC7/LEU-16/S7 therapeutic antibody |
Rituximab |
NA |
MS4A1 |
Whole mAb |
||||
Pre-Made Ublituximab biosimilar, Whole mAb, Anti-MS4A1/CD20 Antibody: Anti-B1/Bp35/CVID5/FMC7/LEU-16/S7 therapeutic antibody |
Ublituximab |
NA |
MS4A1 |
Whole mAb |
||||
Pre-Made Veltuzumab biosimilar, Whole mAb, Anti-MS4A1/CD20 Antibody: Anti-B1/Bp35/CVID5/FMC7/LEU-16/S7 therapeutic antibody |
Veltuzumab |
NA |
MS4A1 |
Whole mAb |
||||
Pre-Made Zuberitamab biosimilar, Whole mAb, Anti-MS4A1/CD20 Antibody: Anti-B1/Bp35/CVID5/FMC7/LEU-16/S7 therapeutic antibody |
Zuberitamab |
NA |
MS4A1 |
Whole mAb |
||||
Pre-Made Technetium (99Mtc) Nofetumomab Merpentan Biosimilar, Radiolabelled Antibody: Anti-MS4A1/CD20 therapeutic antibody |
technetium (99mTc) nofetumomab merpentan |
NA |
MS4A1 |
Radiolabelled antibody |
||||
Pre-Made Tositumomab Biosimilar, Radiolabelled Antibody, Anti-MS4A1/CD20 Antibody: Anti-B1/Bp35/CVID5/FMC7/LEU-16/S7 therapeutic antibody |
tositumomab |
NA |
MS4A1 |
Radiolabelled antibody |
||||
Pre-Made Epitumomab Biosimilar, Whole Mab, Anti-MS4A1/CD20 Antibody: Anti-B1/Bp35/CVID5/FMC7/LEU-16/S7 therapeutic antibody |
epitumomab |
NA |
MS4A1 |
Whole mAb |
